Astellas And Pioneer Group Award Future Innovator Prize To ImmTune TherapiesGemma Cann2024-11-28T15:13:27+00:00March 17th, 2022|Accelerator, News|
From Kitchen Ingredient To Saving Lives – Phenotypeca Pioneers Improved Use Of Baker’s YeastGemma Cann2024-11-28T15:13:44+00:00March 10th, 2022|BioCity Nottingham, News|
Recruiters Plan A Lasting Solution To Teesside’s Skills ShortageGemma Cann2024-11-28T15:14:00+00:00February 28th, 2022|News, Wilton Centre|
AMD Acquisition Of Xilinx CompletesGemma Cann2024-11-28T15:14:13+00:00February 21st, 2022|Edinburgh Technopole, News|
Cellomatics Biosciences Goes For Growth With Senior Business Development HireGemma Cann2024-11-28T15:14:39+00:00February 21st, 2022|News|
Phenotypeca Wins A Third Grant From Innovate UKGemma Cann2024-11-28T15:14:49+00:00February 17th, 2022|News|
Winners Announced For Medilink Midlands Business Awards 2022Gemma Cann2024-11-28T15:16:09+00:00February 15th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Nottingham CRO Bolsters Team With Appointment Of Senior Molecular BiologistGemma Cann2024-11-28T15:29:53+00:00February 14th, 2022|BioCity Nottingham, MediCity Nottingham, News|
Phenotypeca Announces Commencement Of Lab 4.0 ProjectGemma Cann2024-11-28T15:16:33+00:00February 4th, 2022|BioCity Nottingham, News|
Levelling Up White Paper And Life SciencesGemma Cann2024-11-28T14:08:19+00:00February 4th, 2022|Article|
